clonidine and succinylcholine

clonidine has been researched along with succinylcholine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Walland, A1
Böhrer, H; Martin, E; Polarz, H; Völcker, HE; Wolfrum, J1
Mohs, AJ; Peace, MR; Poklis, A; Poklis, JL; Wolf, CE1

Reviews

1 review(s) available for clonidine and succinylcholine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for clonidine and succinylcholine

ArticleYear
Oral clonidine premedication prevents the rise in intraocular pressure following succinylcholine administration.
    German journal of ophthalmology, 1993, Volume: 2, Issue:2

    Topics: Administration, Oral; Aged; Blood Pressure; Clonidine; Clorazepate Dipotassium; Double-Blind Method; Female; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Premedication; Succinylcholine

1993

Other Studies

4 other study(ies) available for clonidine and succinylcholine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Clonidine inhibits electrodermal potentials induced by preganglionic stimulation.
    European journal of pharmacology, 1984, Jun-15, Volume: 102, Issue:1

    Topics: Animals; Autonomic Fibers, Preganglionic; Cats; Clonidine; Electric Stimulation; Female; Galvanic Skin Response; Guanethidine; Hexamethonium Compounds; Male; Reserpine; Stellate Ganglion; Succinylcholine; Vagotomy

1984
Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS).
    Journal of analytical toxicology, 2016, Volume: 40, Issue:8

    Topics: Amides; Analgesics; Anesthetics; Baclofen; Bupivacaine; Caffeine; Chromatography, High Pressure Liquid; Clonidine; Dexamethasone; Ephedrine; Fentanyl; Heparin; Hydromorphone; Ketamine; Mass Spectrometry; Methadone; Midazolam; Morphine; Oxytocin; Parenteral Nutrition Solutions; Phenylephrine; Ropivacaine; Succinylcholine

2016